Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
about
Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasisSmall airway epithelial cells exposure to printer-emitted engineered nanoparticles induces cellular effects on human microvascular endothelial cells in an alveolar-capillary co-culture modelA fragment of human TrpRS as a potent antagonist of ocular angiogenesis.MicroRNA 329 suppresses angiogenesis by targeting CD146Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulationIs the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?New Strategies for the Treatment of Solid Tumors with CAR-T CellsThe Role of Mast Cell Specific Chymases and Tryptases in Tumor AngiogenesisPathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activationEvaporative edge lithography of a liposomal drug microarray for cell migration assays.The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1Monocyte chemotactic protein (MCP)-1 promotes angiogenesis via a novel transcription factor, MCP-1-induced protein (MCPIP)Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancerProliferation and remodeling of the peritubular microcirculation after nephron reduction: association with the progression of renal lesionsPhotoacoustic microscopy: a potential new tool for evaluation of angiogenesis inhibitor.Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endotheliumCooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis.Visualizing dynamics of angiogenic sprouting from a three-dimensional microvasculature model using stage-top optical coherence tomography.Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerRapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patientsAntiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth.Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts.Angiogenic biomarkers in children with congenital heart disease: possible implications.Osteochondral angiogenesis and increased protease inhibitor expression in OA.Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.SNPs detection in DHPS-WDR83 overlapping genes mapping on porcine chromosome 2 in a QTL region for meat pH.Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.Hypertension and hand-foot skin reactions related to VEGFR2 genotype and improved clinical outcome following bevacizumab and sorafenibScheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.New radiotracers for imaging of vascular targets in angiogenesis-related diseases.A novel poly-naphthol compound ST104P suppresses angiogenesis by attenuating matrix metalloproteinase-2 expression in endothelial cells.Toxicity of ochratoxin a and its modulation by antioxidants: a review.Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulvenRevascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure.
P2860
Q23913301-1FAB442A-6836-4D24-A29A-7D957BE95CCCQ23914652-2F1616BD-950C-4541-A9ED-4C6E1CF2B28DQ24292091-32B37A98-F394-4A60-924F-DA3E2C5FA920Q24310981-1CA27600-DA21-4205-8B4A-FED9A6F2871AQ24657187-30E9BB7D-0B2C-464B-B8C5-8CD66B8D28D7Q26741412-6BC222E8-CC7A-46E6-A215-FA7F0F734BA9Q26748500-0159C3E8-E1B3-4E3E-AA98-74798322FDF5Q26826639-FBB96ED7-73D5-48E6-A8B0-A8280701C05CQ26864770-97D97E16-4FA1-4C1A-B860-471F70F6A7A8Q27348323-4094C810-BEB4-4028-B025-B550A1BD5E39Q28075523-D3049533-C1BF-48B4-9B24-F68B9FB14092Q28115465-3EEB2346-C9D3-40BD-8A30-2555AAE247D6Q28304230-9D8EDE86-C083-4A09-8B0D-B1573E0F414EQ28345280-01036947-577E-4E6A-8CC6-2F7E1C6F861CQ30446411-F267A1B7-DFAC-4605-ACA4-17C9E97F86CFQ30486819-643666FB-B35D-47A4-860B-35E39C4D3036Q30498003-352BD90E-BE13-4703-B5AA-0061989187FBQ30838163-DAF003D5-7FD7-4857-95B5-B2D02B6469D6Q33245745-BEA762FC-CE32-4059-A359-9BF47775C4F7Q33312494-7685895B-B42F-4EC5-AF21-B0BC4FA782E5Q33584756-2A01AA66-62FE-4E28-82E5-63F8D2E8BFCDQ33588739-39AD7E60-EC6C-467D-8724-56AD9A2054D4Q33631281-A565C30B-B92B-4076-8ED0-F5BDC50928AFQ33745300-A373AFD4-B8CD-413F-AE6B-6FE5E3594C09Q33865977-F15936BD-2C11-4DE3-87D2-DFF2654E230CQ33869129-BA110D00-AEF8-4001-8CF1-C306FB565834Q33882628-08796551-8840-4D18-B386-A518364558BFQ33894213-C97DF567-831D-4E86-9D6F-F8283E15B284Q33974891-A95E093E-F831-44F0-96A6-91B3EFC4EB16Q34014590-A5AB34DA-CAEB-42C6-87F1-CBCF4D6CCA4DQ34034111-1C18ADB7-72D9-47F0-9BCA-9E6C8D097D1DQ34036032-AF62C00F-DB41-409A-B31B-7634644AABEDQ34039409-3EF4CF31-7A09-4880-AF5D-81089EC6CC21Q34081464-2F78B2CE-4E23-420A-AB7E-7715C076A049Q34109028-67841723-030F-4DF3-8431-8938544CB0F8Q34216877-E1A2B3DD-5D73-481B-BD7A-A4ED1EA818BDQ34358400-10F3EA5E-F6E3-47E7-B9D2-C4AD6A4162B9Q34379821-E392C83B-7184-49D3-A285-93F581AD2916Q34589227-F726EEBB-8D59-473D-91CD-50C34FEE1D56Q34706252-01CA95D7-DABD-49EA-B6E2-9BC931E0DB40
P2860
Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Angiogenesis: potentials for p ...... ses, and chronic inflammation.
@ast
Angiogenesis: potentials for p ...... ses, and chronic inflammation.
@en
type
label
Angiogenesis: potentials for p ...... ses, and chronic inflammation.
@ast
Angiogenesis: potentials for p ...... ses, and chronic inflammation.
@en
prefLabel
Angiogenesis: potentials for p ...... ses, and chronic inflammation.
@ast
Angiogenesis: potentials for p ...... ses, and chronic inflammation.
@en
P1476
Angiogenesis: potentials for p ...... ases, and chronic inflammation
@en
P2093
Griffioen AW
P304
P577
2000-06-01T00:00:00Z